-
Innovation Ranking
NewInnovation Ranking – Accelerate Diagnostics Inc
Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company engaged in the development and commercialization of instruments for the identification and testing of antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, a platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit, which provides ID and AST results for patients with bacteremia or fungemia. It operates a manufacturing facility in Tucson, Arizona. The company sells products directly...
-
Company Insights
Innovation and Patenting activity of Accelerate Diagnostics Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Accelerate Diagnostics Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Track & Monitor
Artificial intelligence in automotive: Predictive acceleration control
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Predictive acceleration control segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Sector Analysis
NewCanada Source Tourism Insight by Domestic and Outbound Tourism, Key Destinations and Tourist Profiles, 2024 Update
Canada Source Tourism Report Overview The total outbound trips from Canada during 2023 reached 35.76 million, showing an accelerated recovery post the pandemic. The projected compound annual growth rate (CAGR) for international departures is more than 7% from 2023 to 2027. The US was the top destination market for Canadian outbound travelers in 2023. The Canada source tourism market research report provides an in-depth analysis of source markets and infrastructure developments. The report also offers an in-depth understanding of Canada's...
-
Thematic Analysis
NewQuantum Computing in Aerospace, Defense and Security – Thematic Intelligence
Quantum Computing in Aerospace and Defense Thematic Report Overview Quantum computing aims to use the counterintuitive behavior of sub-atomic particles to spawn computers of mind-boggling power. Quantum computers can simulate large, uncertain, complicated systems in seconds, including the weather, financial markets, chemical reactions, molecules, and neurons in the human brain. In the aerospace and defense industry quantum capabilities are theorized to have applications in sensing, communications, computing, navigation, and electronic warfare, with the unique properties of quantum mechanics enhancing situational...
-
Company Insights
NewPrudential – Digital Transformation Strategies
Prudential Digital Transformation Strategies Overview Prudential has been focusing on using cloud, big data, mobile payments, and artificial intelligence to digitally transform its operations. The annual ICT spending of Prudential was estimated at $145.4 million for 2023. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. Prudential is a financial services group that offers long-term savings and protection products. Through its subsidiaries, the group provides retirement benefits and insurance coverage for various...
-
Sector Analysis
NewKuwait Telecom Operators Country Intelligence Report
Kuwait Telecom Operators Country Intelligence Overview The total telecom service revenue in Kuwait was $2.3 billion and will increase at a CAGR of 2% supported by revenue growth in mobile data and fixed broadband segments. The revenue growth can also be attributed to the telecom regulator’s plans to improve and accelerate infrastructure investment to deliver high-quality internet service in the country. Kuwait Telecom Services Market Outlook, 2023-2028 ($ Billion) Buy the Full Report to Gain More Information on the Kuwait...
-
Company Insights
NewGroupe BPCE – Digital Transformation Strategies
Groupe BPCE Digital Transformation Strategies Overview Groupe BPCE has been leveraging artificial intelligence, blockchain, digital payment technologies, and robotic process automation to digitally transform both its front and back-office operations. The annual ICT spending of BPCE was estimated to be $1.2 billion for 2023. A major share of this spending was for acquiring software, network & communications, and hardware from vendors. offers a wide range of financial products and services to retail customers, companies, and institutions through its eight lines...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ponatinib Hydrochloride in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ponatinib Hydrochloride in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ponatinib Hydrochloride in T-Cell Acute...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ponatinib Hydrochloride in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ponatinib Hydrochloride in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ponatinib Hydrochloride in Acute Myelocytic Leukemia...